TrialTransfusion2017

Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma.

Isabell Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.